Quest Diagnostics ( NYSE:DGX – Get Rating ) posted its quarterly earnings data on Thursday. The medical research company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.97 by $0.07, Briefing.com reports. The business had revenue of $2.33 billion during the quarter, compared to analyst estimates of $2.20 billion. Quest Diagnostics had a net margin of 9.57% and a return on equity of 18.84%. The business's revenue for the quarter was down 10.7% compared to the same quarter last year.

https://www.dailypolitical.com/2023/04/28/quest-diagnostics-nysedgx-announces-earnings-results.html

#dailypolitical